Both a higher and lower dose of the extract was shown to reduce appetite and cravings.
A recent study1 found that a bitter hop extract (Amarasate) acts as a GLP-1 activator, reducing appetite and food cravings. Amarasate is the active ingredient in the supplement Calocurb. In the study, 30 adult women fasted for 24 hours on three occasions and given an ad libitum meal to break each fast. As a treatment, participants were given either placebo or two doses of the bitter hop extract (a high dose: 250 mg or low dose: 125 mg). Results showed that both the high and low dose treatment groups experienced significant reductions in appetite and food cravings compared to control.
The researchers note that because of the participants’ fasting, baseline values of hunger were already elevated. So, while appetite suppression was observed, the participants would still be considered hungry. That is to say, the supplement did not remove hunger, just blunted an increase in hunger. Based on previous research, the suppression of hunger from the extract may be related to the inhibition of pro-appetite ghrelin action by stimulating the increase of enteroendocrine cell hormones, which is a potent inhibitor of ghrelin action.
According to the company’s press release, this latest study is the third to validate the ingredient’s benefits, and a fourth is currently underway in 150 men and women. That study will cost $2 million, with results expected in the first half of 2025. The research is supported by funding from the New Zealand government, which has devoted $30 million to the development of a “gut-targeted plant-based nutraceutical for appetite control with Plant and Food Research, a government-owned Crown Research Institute.” They hypothesized that “bitter taste receptors would be found in the gut, due to historical evidence that bitterness modulates appetite.”
Over 1,000 potential candidates were tested, eventually leading to hops, which became the trademarked Amarasate.
Reference
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.